According to sources familiar with the matter at hand, Warburg Pincus LLC aims to raise $16 billion from investors for its biggest ever flagship global private equity fund. Warburg Pincus is in the “early stages of raising Warburg Pincus Global… Read More ›
In a statement, Bristol-Myers Squibb Co and Eisai Co said, they had entered into an agreement to jointly develop and market an experimental cancer drug worth up to $3.10 billion. Bristol-Myers would pay $650 million, including for research and development… Read More ›
In an interview to German magazine Der Spiegel, the European Union’s Economics Commissioner Paolo Gentiloni said, the EU would need around $1.63 trillion (1.5 trillion euros) to mitigate issues revolving around the coronavirus crisis. “The Eurogroup has now made proposals… Read More ›
On Thursday, the European Union commissioner stated, the bloc was weighing options which includes measures to support those sectors which have been adversely hit by China’s coronavirus; it would however need more time to assess its precise economic impact. “It… Read More ›
Drugmakers, including Gilead Sciences Inc, Bristol-Myers Squibb Co, and Biogen Inc have hiked their U.S. list prices on more than 50 drugs, according to data analyzed by 3 Axis Advisors, a healthcare research firm. On Tuesday, there were media reports… Read More ›
On Monday, British Prime Minister Boris Johnson disclosed he has placed further cuts on corporation taxes on hold and he will be pumping in more money into services such as healthcare and made it a central issue in the December… Read More ›
Bernard J. Tyson, chairman and chief executive officer of not-for-profit health insurer Kaiser Permanente, died in his sleep aged 60, said the company in a statement. Tyson, who rose to the top job since 2013, was the company’s first black… Read More ›
If the development has cascading effect and more retailers pull J&J’s baby talc powder from shelves, it could significantly impact its earnings. Already J&J is facing lawsuits over allegations of asbestos in its talc. Following U.S. healthcare conglomerate Johnson &… Read More ›
The decision comes in the wake of continuing regulatory scrutiny by antitrust regulators in the UK and U.S. over its takeover offer. Following a continuation of regulatory reviews in the United States and Britain, Roche and Spark Therapeutics announced another… Read More ›
The Japanese healthcare firm wants to acquire Bristol-Myers Squibb’s over-the-counter drugs business. On Wednesday, France-headquartered Bristol-Myers Squibb Co has received an offer from Taisho Pharmaceutical Holdings Co Ltd, a Japanese healthcare firm, to acquire its over-the-counter drugs business UPSA for… Read More ›
manageria.biz 